Exact Mass: 448.1911
Exact Mass Matches: 448.1911
Found 411 metabolites which its exact mass value is equals to given mass value 448.1911
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lonchocarpenin
A hydroxycoumarin that is 2H,8H-benzo[1,2-b:5,4-b]dipyran-2-one substituted by a hydroxy group at position 4, a methoxy group at position 5, 4-methoxyphenyl group at position 3 and two methyl groups at position 8 respectively.
1,3-Benzenedicarbonitrile, 2-[[4-[[2-(acetyloxy)ethyl]butylamino]-2-methylphenyl]azo]-5-nitro-
Tarazepide
Manuifolin Q
Pierreione C
A methoxyisoflavone that is isoflavone substituted by methoxy groups at positions 5 and 3, a prenyloxy group at position 4 and a dimethylpyran ring fused across positions 6 and 7. Isolated from Antheroporum pierrei, it exhibits antineoplastic activity.
Prenylcandidusin B
A member of the class of dibenzofurans that is 1,4,7,8-tetramethoxydibenzo[b,d]furan substituted by a 4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl substituent at position 3. It has been isolated from Aspergillus taichungensis.
3beta-norpinan-2-one 3-O-beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranoside
5-hydroxy-6-methyl-2-methoxy-[6,6-dimethylpyrano(2,3:7,8)][6,6dimethylpyrano(2,3:4,5)]-(2S)-flavone
Ala Asp Phe Pro
Ala Asp Ile Met
Ala Asp Leu Met
Ala Asp Met Ile
Ala Asp Met Leu
Ala Asp Pro Phe
Ala Glu Met Val
Ala Glu Val Met
Ala Phe Asp Pro
Ala Phe Pro Asp
Ala Ile Asp Met
Ala Ile Met Asp
Ala Leu Asp Met
Ala Leu Met Asp
Ala Met Asp Ile
Ala Met Asp Leu
Ala Met Glu Val
Ala Met Ile Asp
Ala Met Leu Asp
Ala Met Met Pro
Ala Met Pro Met
Ala Met Val Glu
Ala Pro Asp Phe
Ala Pro Phe Asp
Ala Pro Met Met
Ala Val Glu Met
Ala Val Met Glu
Cys Asp Ile Val
Cys Asp Leu Val
Cys Asp Val Ile
Cys Asp Val Leu
Cys Glu Val Val
Cys Gly Asn Arg
Cys Gly Arg Asn
Cys Ile Asp Val
Cys Ile Val Asp
Cys Leu Asp Val
Cys Leu Val Asp
Cys Met Pro Val
Cys Met Val Pro
Cys Asn Gly Arg
Cys Asn Arg Gly
Cys Pro Met Val
Cys Pro Val Met
Cys Arg Gly Asn
Cys Arg Asn Gly
Cys Val Asp Ile
Cys Val Asp Leu
Cys Val Glu Val
Cys Val Ile Asp
Cys Val Leu Asp
Cys Val Met Pro
Cys Val Pro Met
Cys Val Val Glu
Asp Ala Phe Pro
Asp Ala Ile Met
Asp Ala Leu Met
Asp Ala Met Ile
Asp Ala Met Leu
Asp Ala Pro Phe
Asp Cys Ile Val
Asp Cys Leu Val
Asp Cys Val Ile
Asp Cys Val Leu
Asp Phe Ala Pro
Asp Phe Pro Ala
Asp Ile Ala Met
Asp Ile Cys Val
Asp Ile Met Ala
Asp Ile Val Cys
Asp Leu Ala Met
Asp Leu Cys Val
Asp Leu Met Ala
Asp Leu Val Cys
Asp Met Ala Ile
Asp Met Ala Leu
Asp Met Ile Ala
Asp Met Leu Ala
Asp Pro Ala Phe
Asp Pro Phe Ala
Asp Val Cys Ile
Asp Val Cys Leu
Asp Val Ile Cys
Asp Val Leu Cys
Glu Ala Met Val
Glu Ala Val Met
Glu Cys Val Val
Glu Phe Gly Pro
Glu Phe Pro Gly
Glu Gly Phe Pro
Glu Gly Ile Met
Glu Gly Leu Met
Glu Gly Met Ile
Glu Gly Met Leu
Glu Gly Pro Phe
Glu Ile Gly Met
Glu Ile Met Gly
Glu Leu Gly Met
Glu Leu Met Gly
Glu Met Ala Val
Glu Met Gly Ile
Glu Met Gly Leu
Glu Met Ile Gly
Glu Met Leu Gly
Glu Met Val Ala
Glu Pro Phe Gly
Glu Pro Gly Phe
Glu Val Ala Met
Glu Val Cys Val
Glu Val Met Ala
Glu Val Val Cys
Phe Ala Asp Pro
Phe Ala Pro Asp
Phe Asp Ala Pro
Phe Asp Pro Ala
Phe Glu Gly Pro
Phe Glu Pro Gly
Phe Gly Glu Pro
Phe Gly Pro Glu
Phe Pro Ala Asp
Phe Pro Asp Ala
Phe Pro Glu Gly
Phe Pro Gly Glu
Gly Cys Asn Arg
Gly Cys Arg Asn
Gly Glu Phe Pro
Gly Glu Ile Met
Gly Glu Leu Met
Gly Glu Met Ile
Gly Glu Met Leu
Gly Glu Pro Phe
Gly Phe Glu Pro
Gly Phe Pro Glu
Gly Ile Glu Met
Gly Ile Met Glu
Gly Leu Glu Met
Gly Leu Met Glu
Gly Met Glu Ile
Gly Met Glu Leu
Gly Met Ile Glu
Gly Met Leu Glu
Gly Asn Cys Arg
Gly Asn Arg Cys
Gly Pro Glu Phe
Gly Pro Phe Glu
Gly Arg Cys Asn
Gly Arg Asn Cys
Ile Ala Asp Met
Ile Ala Met Asp
Ile Cys Asp Val
Ile Cys Val Asp
Ile Asp Ala Met
Ile Asp Cys Val
Ile Asp Met Ala
Ile Asp Val Cys
Ile Glu Gly Met
Ile Glu Met Gly
Ile Gly Glu Met
Ile Gly Met Glu
Ile Met Ala Asp
Ile Met Asp Ala
Ile Met Glu Gly
Ile Met Gly Glu
Ile Val Cys Asp
Ile Val Asp Cys
Leu Ala Asp Met
Leu Ala Met Asp
Leu Cys Asp Val
Leu Cys Val Asp
Leu Asp Ala Met
Leu Asp Cys Val
Leu Asp Met Ala
Leu Asp Val Cys
Leu Glu Gly Met
Leu Glu Met Gly
Leu Gly Glu Met
Leu Gly Met Glu
Leu Met Ala Asp
Leu Met Asp Ala
Leu Met Glu Gly
Leu Met Gly Glu
Leu Val Cys Asp
Leu Val Asp Cys
Met Ala Asp Ile
Met Ala Asp Leu
Met Ala Glu Val
Met Ala Ile Asp
Met Ala Leu Asp
Met Ala Met Pro
Met Ala Pro Met
Met Ala Val Glu
Met Cys Pro Val
Met Cys Val Pro
Met Asp Ala Ile
Met Asp Ala Leu
Met Asp Ile Ala
Met Asp Leu Ala
Met Glu Ala Val
Met Glu Gly Ile
Met Glu Gly Leu
Met Glu Ile Gly
Met Glu Leu Gly
Met Glu Val Ala
Met Gly Glu Ile
Met Gly Glu Leu
Met Gly Ile Glu
Met Gly Leu Glu
Met Ile Ala Asp
Met Ile Asp Ala
Met Ile Glu Gly
Met Ile Gly Glu
Met Leu Ala Asp
Met Leu Asp Ala
Met Leu Glu Gly
Met Leu Gly Glu
Met Met Ala Pro
Met Met Pro Ala
Met Pro Ala Met
Met Pro Cys Val
Met Pro Met Ala
Met Pro Thr Thr
Met Pro Val Cys
Met Thr Pro Thr
Met Thr Thr Pro
Met Val Ala Glu
Met Val Cys Pro
Met Val Glu Ala
Met Val Pro Cys
Asn Cys Gly Arg
Asn Cys Arg Gly
Asn Gly Cys Arg
Asn Gly Arg Cys
Asn Asn Thr Thr
Asn Gln Ser Thr
Asn Gln Thr Ser
Asn Arg Cys Gly
Asn Arg Gly Cys
Asn Ser Gln Thr
Asn Ser Thr Gln
Asn Thr Asn Thr
Asn Thr Gln Ser
Asn Thr Ser Gln
Asn Thr Thr Asn
Pro Ala Asp Phe
Pro Ala Phe Asp
Pro Ala Met Met
Pro Cys Met Val
Pro Cys Val Met
Pro Asp Ala Phe
Pro Asp Phe Ala
Pro Glu Phe Gly
Pro Glu Gly Phe
Pro Phe Ala Asp
Pro Phe Asp Ala
Pro Phe Glu Gly
Pro Phe Gly Glu
Pro Gly Glu Phe
Pro Gly Phe Glu
Pro Met Ala Met
Pro Met Cys Val
Pro Met Met Ala
Pro Met Thr Thr
Pro Met Val Cys
Pro Thr Met Thr
Pro Thr Thr Met
Pro Val Cys Met
Pro Val Met Cys
Gln Asn Ser Thr
Gln Asn Thr Ser
Gln Gln Ser Ser
Gln Ser Asn Thr
Gln Ser Gln Ser
Gln Ser Ser Gln
Gln Ser Thr Asn
Gln Thr Asn Ser
Gln Thr Ser Asn
Arg Cys Gly Asn
Arg Cys Asn Gly
Arg Gly Cys Asn
Arg Gly Asn Cys
Arg Asn Cys Gly
Arg Asn Gly Cys
Ser Asn Gln Thr
Ser Asn Thr Gln
Ser Gln Asn Thr
Ser Gln Gln Ser
Ser Gln Ser Gln
Ser Gln Thr Asn
Ser Ser Gln Gln
Ser Thr Asn Gln
Ser Thr Gln Asn
Thr Met Pro Thr
Thr Met Thr Pro
Thr Asn Asn Thr
Thr Asn Gln Ser
Thr Asn Ser Gln
Thr Asn Thr Asn
Thr Pro Met Thr
Thr Pro Thr Met
Thr Gln Asn Ser
Thr Gln Ser Asn
Thr Ser Asn Gln
Thr Ser Gln Asn
Thr Thr Met Pro
Thr Thr Asn Asn
Thr Thr Pro Met
Val Ala Glu Met
Val Ala Met Glu
Val Cys Asp Ile
Val Cys Asp Leu
Val Cys Glu Val
Val Cys Ile Asp
Val Cys Leu Asp
Val Cys Met Pro
Val Cys Pro Met
Val Cys Val Glu
Val Asp Cys Ile
Val Asp Cys Leu
Val Asp Ile Cys
Val Asp Leu Cys
Val Glu Ala Met
Val Glu Cys Val
Val Glu Met Ala
Val Glu Val Cys
Val Ile Cys Asp
Val Ile Asp Cys
Val Leu Cys Asp
Val Leu Asp Cys
Val Met Ala Glu
Val Met Cys Pro
Val Met Glu Ala
Val Met Pro Cys
Val Pro Cys Met
Val Pro Met Cys
Val Val Cys Glu
Val Val Glu Cys
22-dimethylarsinoyl-(5Z,8Z, 11Z,14Z,17Z,20Z)-docosahexaenoic acid
Quinoline,8,8-[oxybis(2,1-ethanediyloxy-2,1-ethanediyloxy)]bis-
DEBRISOQUIN SULFATE
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Karenitecin
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor
1H-Benzimidazole-1-acetamide,N-cyclopentyl-2-[[2-(3,4-dihydro-2(1H)-isoquinolinyl)-2-oxoethyl]thio]-(9CI)
n-(1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1h-1,4-benzodiazepin-3-yl)-5,6-dihydro-4h-pyrrolo[3,2,1-ij]quinoline-2-carboxamide
N-[2-(3,4-diethoxyphenyl)ethyl]-4-(phenylmethyl)-5-thieno[3,2-b]pyrrolecarboxamide
Technetium Tc-99m disofenin
V - Various > V09 - Diagnostic radiopharmaceuticals > V09D - Hepatic and reticulo endothelial system > V09DA - Technetium (99mtc) compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
2-(6-Chloro-3-{[2,2-difluoro-2-(2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluoro-3-methyl-6-pyridinyl)methyl]acetamide
N-[3-(cyclohexylthio)propyl]-2-[[5-methyl-2-(3-methylphenyl)-4-oxazolyl]methylsulfinyl]acetamide
4-[[9-[(3R)-3-oxolanyl]-8-(2,4,6-trifluoroanilino)-2-purinyl]amino]-1-cyclohexanol
1-(3-Sulfopropyl)-4-[(1e,3e)-3-(1,3,3-Trimethyl-1,3-Dihydro-2h-Indol-2-Ylidene)prop-1-En-1-Yl]quinolinium
D004396 - Coloring Agents > D002232 - Carbocyanines
1-(4-Fluorophenyl)-4-[[1-(2-phenylethyl)-5-tetrazolyl]-thiophen-2-ylmethyl]piperazine
(2S,3S,3aR,9bR)-7-(3-fluorophenyl)-3-(hydroxymethyl)-1-methyl-6-oxo-N-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1S,9R,10R,11R)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-N-(2-pyridin-4-ylethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-N-(2-pyridin-4-ylethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
3-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
3-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
(2R,3R,3aS,9bS)-7-(3-fluorophenyl)-3-(hydroxymethyl)-1-methyl-6-oxo-N-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
3-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
(3R)-3-{[(3R)-3-{[(3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoyl]oxy}butanoyl]oxy}butanoic acid
22-dimethylarsinoyl-(5Z,8Z, 11Z,14Z,17Z,20Z)-docosahexaenoic acid
BAY-293
BAY-293, a valuable chemical probe, blocks RAS activation via disruption of the KRAS-SOS1 interaction with an IC50 of 21 nM. BAY-293 is a potent inhibitor of Son of Sevenless 1 (SOS1). SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS[1].
CNT2 inhibitor-1
CNT2 inhibitor-1 is a potent concentrative nucleoside transporter 2 Inhibitor (CNT2), with an IC50 of 640 nM for hCNT2.
3-(2h-1,3-benzodioxol-5-yl)-7-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-6-methoxychromen-4-one
3-(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)-4-hydroxy-5-[(7-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)methylidene]furan-2-one
Bakkenolide-IIIa
{"Ingredient_id": "HBIN017540","Ingredient_name": "Bakkenolide-IIIa","Alias": "NA","Ingredient_formula": "C24H32O6S","Ingredient_Smile": "CC=C(C)C(=O)OC1C2C(CCC(C2(CC13C(=C)COC3=O)C)C)OC(=O)C=CSC","Ingredient_weight": "448.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35681","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706161","DrugBank_id": "NA"}